Knowledge and decisions about maternal immunisation by pregnant women in Aotearoa New Zealand.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
14 Jun 2022
Historique:
received: 23 03 2022
accepted: 07 06 2022
entrez: 13 6 2022
pubmed: 14 6 2022
medline: 16 6 2022
Statut: epublish

Résumé

Maternal vaccinations for influenza and pertussis are recommended in New Zealand to protect mothers and their infant from infection. However, maternal immunisation coverage in New Zealand is suboptimal. Furthermore, there is unacceptable inequitable maternal immunisation rates across the country with Māori and Pacific women having significantly lower maternal immunisation rates than those of other New Zealanders. This research set out to explore what pregnant/recently pregnant Māori and Pacific women knew about immunisation during pregnancy and what factors influenced their decision to be vaccinated. A semi-structured interview guide was developed with questions focusing on knowledge of pertussis and influenza vaccination during pregnancy and decision-making. Māori and Pacific women aged over 16 years were purposively sampled and interviewed in Dunedin and Gisborne, New Zealand between May and August 2021. Interviews were analysed following a directed qualitative content approach. Data were arranged into coding nodes based on the study aims (deductive analysis) informed by previous literature and within these participant experiences were inductively coded into themes and subthemes. Not all women were aware of maternal vaccine recommendations or they diseases they protected against. Many underestimated how dangerous influenza and pertussis could be and some were more concerned about potential harms of the vaccine. Furthermore, understanding potential harms of infection and protection provided by vaccination did not necessarily mean women would choose to be vaccinated. Those who decided to vaccinate felt well-informed, had vaccination recommended by their healthcare provider, and did so to protect their and their infant's health. Those who decided against vaccination were concerned about safety of the vaccines, lacked the information they needed, were not offered the vaccine, or did not consider vaccination a priority. There is a lack of understanding about vaccine benefits and risks of vaccine-preventable diseases which can result in the reinforcement of negative influences such as the fear of side effects. Furthermore, if vaccine benefits are not understood, inaccessibility of vaccines and the precedence of other life priorities may prevent uptake. Being well-informed and supported to make positive decisions to vaccinate in pregnancy is likely to improve vaccine coverage in Māori and Pacific Island New Zealanders.

Sections du résumé

BACKGROUND BACKGROUND
Maternal vaccinations for influenza and pertussis are recommended in New Zealand to protect mothers and their infant from infection. However, maternal immunisation coverage in New Zealand is suboptimal. Furthermore, there is unacceptable inequitable maternal immunisation rates across the country with Māori and Pacific women having significantly lower maternal immunisation rates than those of other New Zealanders.
METHODS METHODS
This research set out to explore what pregnant/recently pregnant Māori and Pacific women knew about immunisation during pregnancy and what factors influenced their decision to be vaccinated. A semi-structured interview guide was developed with questions focusing on knowledge of pertussis and influenza vaccination during pregnancy and decision-making. Māori and Pacific women aged over 16 years were purposively sampled and interviewed in Dunedin and Gisborne, New Zealand between May and August 2021. Interviews were analysed following a directed qualitative content approach. Data were arranged into coding nodes based on the study aims (deductive analysis) informed by previous literature and within these participant experiences were inductively coded into themes and subthemes.
RESULTS RESULTS
Not all women were aware of maternal vaccine recommendations or they diseases they protected against. Many underestimated how dangerous influenza and pertussis could be and some were more concerned about potential harms of the vaccine. Furthermore, understanding potential harms of infection and protection provided by vaccination did not necessarily mean women would choose to be vaccinated. Those who decided to vaccinate felt well-informed, had vaccination recommended by their healthcare provider, and did so to protect their and their infant's health. Those who decided against vaccination were concerned about safety of the vaccines, lacked the information they needed, were not offered the vaccine, or did not consider vaccination a priority.
CONCLUSIONS CONCLUSIONS
There is a lack of understanding about vaccine benefits and risks of vaccine-preventable diseases which can result in the reinforcement of negative influences such as the fear of side effects. Furthermore, if vaccine benefits are not understood, inaccessibility of vaccines and the precedence of other life priorities may prevent uptake. Being well-informed and supported to make positive decisions to vaccinate in pregnancy is likely to improve vaccine coverage in Māori and Pacific Island New Zealanders.

Identifiants

pubmed: 35698133
doi: 10.1186/s12913-022-08162-4
pii: 10.1186/s12913-022-08162-4
pmc: PMC9192336
doi:

Substances chimiques

Influenza Vaccines 0
Pertussis Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

779

Subventions

Organisme : Health Research Council of New Zealand
ID : 20/1242

Informations de copyright

© 2022. The Author(s).

Références

J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Vaccines (Basel). 2022 Jan 20;10(2):
pubmed: 35214609
J Obstet Gynaecol Can. 2008 May;30(5):404-10
pubmed: 18505664
Obstet Gynecol. 2013 Apr;121(4):741-749
pubmed: 23635673
J Prim Health Care. 2016 Dec;8(4):344-350
pubmed: 29530159
J Clin Nurs. 2022 Jun;31(11-12):1531-1546
pubmed: 34423873
Med J Aust. 2019 Jun;210(10):454-462
pubmed: 31006130
N Z Med J. 2016 Apr 22;129(1433):78-85
pubmed: 27349165
Vaccines (Basel). 2022 Jan 04;10(1):
pubmed: 35062737
Nurse Res. 2006;13(3):7-21
pubmed: 16594366
Vaccine. 2018 May 3;36(19):2687-2693
pubmed: 29627238
Res Nurs Health. 1997 Apr;20(2):169-77
pubmed: 9100747
Vaccine. 2014 Mar 26;32(15):1736-44
pubmed: 24486366
Hum Vaccin Immunother. 2016 Apr 2;12(4):857-65
pubmed: 26552807
Vaccine. 2020 Oct 7;38(43):6766-6776
pubmed: 32868133
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
J Paediatr Child Health. 2007 Sep;43(9):617-22
pubmed: 17608654
BMC Nurs. 2017 Jun 12;16:31
pubmed: 28615990
Vaccines (Basel). 2020 Mar 29;8(2):
pubmed: 32235360
Vaccine. 2014 Aug 6;32(36):4602-13
pubmed: 24996123
N Z Med J. 2014 May 02;127(1393):52-61
pubmed: 24816956
BMJ. 2010 Mar 18;340:c1279
pubmed: 20299694
Public Health. 2017 May;146:10-14
pubmed: 28404461
N Z Med J. 2014 Oct 17;127(1404):53-61
pubmed: 25331312
Vaccine. 2018 Oct 22;36(44):6473-6479
pubmed: 28811050
Vaccine. 2015 Nov 25;33(47):6420-9
pubmed: 26320417
Midwifery. 2021 Apr;95:102936
pubmed: 33592369
Vaccine. 2019 Oct 8;37(43):6390-6396
pubmed: 31515147
Int J Equity Health. 2019 Oct 30;18(1):168
pubmed: 31666134
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S3-8
pubmed: 22920056
J Prim Health Care. 2018 Mar;10(1):62-67
pubmed: 30068453
Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):417-424
pubmed: 29139107

Auteurs

Amber Young (A)

Division of Health Sciences , Kōhatu-Centre for Hauora Māori, Otago Medical School, University of Otago, PO Box 56 , 9054, Dunedin, New Zealand. amber.young@otago.ac.nz.

Nadia A Charania (NA)

Department of Public Health, School of Public Health and Interdisciplinary Studies, Auckland University of Technology, Auckland, New Zealand.

Natalie Gauld (N)

Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.
School of Pharmacy, University of Auckland, Auckland, New Zealand.

Pauline Norris (P)

Va'a o Tautai - Centre for Pacific Health, University of Otago, Dunedin, New Zealand.

Nikki Turner (N)

Immunisation Advisory Centre, Department of General Practice and Primary Care, University of Auckland, Auckland, New Zealand.

Esther Willing (E)

Division of Health Sciences , Kōhatu-Centre for Hauora Māori, Otago Medical School, University of Otago, PO Box 56 , 9054, Dunedin, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH